Dicerna Pharmaceuticals
DRNA
#4023
Rank
โ‚น272.87 B
Marketcap
โ‚น3,503
Share price
0.00%
Change (1 day)
18,293.77%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: โ‚น272.87 Billion

As of February 2026 Dicerna Pharmaceuticals has a market cap of โ‚น272.87 Billion. This makes Dicerna Pharmaceuticals the world's 4023th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022โ‚น246.40 B11.18%
2021โ‚น221.63 B81.58%
2020โ‚น122.05 B8.55%
2019โ‚น112.44 B120.53%
2018โ‚น50.98 B71.23%
2017โ‚น29.77 B633.1%
2016โ‚น4.06 B-75%
2015โ‚น16.24 B-12.5%
2014โ‚น18.56 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น13.776 T 4,948.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น16.870 T 6,082.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น25.240 T 9,149.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚น51.77 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น4.092 T 1,399.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น889.55 B 225.99%๐Ÿ‡บ๐Ÿ‡ธ USA